Advertisement
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
The trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus (OLP), a highly morbid condition with no effective treatment.
In March 2023, Lipella created a five-member Scientific Advisory Board in Oral Health, made up of a group of highly regarded experts in oral medicine, to focus on the development of LP-310.
read more
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.
RTTNews
|
939 hari yang lalu
Indian Rupee Rises To 3-day High Against U.S. Dollar
The Indian rupee strengthened against the U.S. dollar in the Asian session on Thursday, as the monetary policy outlook from the Reserve Bank of India (RBI) helped the Indian currency amid rising trade tensions with the United States (US).
RTTNews
|
3 minit yang lalu
Sensex, Nifty End Marginally Higher After Early Losses
Indian shares reversed early losses to end on a flat note Thursday. A cautious undertone prevailed after U.S. President Donald Trump signed an executive order imposing an additional 25 percent tariff on India as a "penalty" in response to its continued purchase of Russian oil.
RTTNews
|
12 minit yang lalu
European Shares Mostly Higher Before BoE Rate Decision
European stocks were mostly higher on Thursday, with U.K. markets underperforming ahead of the Bank of England's interest-rate decision.
RTTNews
|
1j 16min yang lalu
Commodity Currencies Rise Amid Risk-On Mood, Strong China Export Data
The commodity currencies such as Australia, the New Zealand and the Canadian dollars strengthened against their major counterparts in the Asian session on Thursday amid increased risk appetite by the investors, after U.S. President Donald Trump said the U.S. was closing in on the trade deal with China. Traders also remain optimistic about the U.S. Fed cutting interest rates as early as September based on the recent economic data from the U.S.
RTTNews
|
1j 40min yang lalu
Asian Shares End Mostly Higher As Trump's New Tariffs Go Into Effect
Asian stocks advanced on Thursday as U.S. President Donald Trump's sweeping new tariffs take effect against dozens of countries.
RTTNews
|
1j 53min yang lalu
China Exports Growth Accelerates; Imports Rise Unexpectedly
China's exports logged a robust growth in July as the sharp decline in shipments to the US was offset by the rise in exports to the EU and other markets, official data revealed Thursday. Exports surged 7.2 percent on a yearly basis, following June's 5.8 percent increase, the customs office reported. Exports were forecast to climb 5.4 percent.
RTTNews
|
2j 13min yang lalu
UK House Prices Rise At Fastest Pace In 6 Months
UK house prices grew at the fastest pace in six months in July as the property market started to stabilize following the end of the stamp duty holiday, data from the mortgage lender Halifax showed on Thursday. House prices increased by more-than-expected 0.4 percent in July from June. Prices were expected to grow at a steady pace of 0.1 percent in July. Moreover, this was the fastest growth sinc
RTTNews
|
2j 53min yang lalu
